NMRA
Neumora Therapeutics Inc
NASDAQ · Pharmaceuticals
$2.12
+0.16 (+8.16%)
Open$2.02
Previous Close$1.96
Day High$2.16
Day Low$1.98
52W High$20.66
52W Low$8.91
Volume—
Avg Volume68.2K
Market Cap354.23M
P/E Ratio15.84
EPS$1.02
SectorPharmaceuticals
Analyst Ratings
Buy
14 analysts
Price Target
+717.9% upside
Current
$2.12
$2.12
Target
$17.34
$17.34
$11.85
$17.34 avg
$21.76
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 131.86M | 126.94M | 118.45M |
| Net Income | 20.35M | 17.55M | 19.05M |
| Profit Margin | 15.4% | 13.8% | 16.1% |
| EBITDA | 29.65M | 29.50M | 31.41M |
| Free Cash Flow | 15.46M | 12.66M | 10.19M |
| Rev Growth | -7.9% | +5.6% | -2.9% |
| Debt/Equity | 0.29 | 0.31 | 0.30 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |